Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron D Falchook

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 6, 2015
Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern PatientsJoseph M Caster, Aaron D Falchook, Laura H Hendrix, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trialsReshma Jagsi, Aaron D Falchook, Laura H Hendrix, et al.
Gynecologic Oncology|May 31, 2015
Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapyAlaattin Ozen, Aaron D Falchook, Mahesh A Varia, et al.
JAMA Oncology|September 23, 2018
Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly MenJustin G Trogdon, Aaron D Falchook, Ramsankar Basak, et al.
Journal of the National Cancer Institute|September 28, 2017
Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 YearsAaron D Falchook, Stacie B Dusetzina, Fang Tian, et al.
Urologic Oncology|November 4, 2015
Stage at presentation and survival outcomes of patients with Gleason 8-10 prostate cancer and low prostate-specific antigenAaron D Falchook, Neil E Martin, Ramsankar Basak, et al.
European Urology Oncology|June 4, 2019
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year OutcomesDonald B Fuller, Aaron D Falchook, Tami Crabtree, et al.
Cancer|October 6, 2020
Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance)Ronald C Chen, Toni K Choueiri, Marion Feuilly, et al.
Journal of the American Medical Informatics Association : JAMIA|March 31, 2016
Toward a better understanding of task demands, workload, and performance during physician-computer interactionsLukasz M Mazur, Prithima R Mosaly, Carlton Moore, et al.
Frontiers in Oncology|February 8, 2017
Evaluation of PET/MRI for Tumor Volume Delineation for Head and Neck CancerKyle Wang, Brandon T Mullins, Aaron D Falchook, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|April 6, 2015
Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern PatientsJoseph M Caster, Aaron D Falchook, Laura H Hendrix, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trialsReshma Jagsi, Aaron D Falchook, Laura H Hendrix, et al.
Gynecologic Oncology|May 31, 2015
Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapyAlaattin Ozen, Aaron D Falchook, Mahesh A Varia, et al.
JAMA Oncology|September 23, 2018
Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly MenJustin G Trogdon, Aaron D Falchook, Ramsankar Basak, et al.
Journal of the National Cancer Institute|September 28, 2017
Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 YearsAaron D Falchook, Stacie B Dusetzina, Fang Tian, et al.
Urologic Oncology|November 4, 2015
Stage at presentation and survival outcomes of patients with Gleason 8-10 prostate cancer and low prostate-specific antigenAaron D Falchook, Neil E Martin, Ramsankar Basak, et al.
European Urology Oncology|June 4, 2019
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year OutcomesDonald B Fuller, Aaron D Falchook, Tami Crabtree, et al.
Cancer|October 6, 2020
Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance)Ronald C Chen, Toni K Choueiri, Marion Feuilly, et al.
Journal of the American Medical Informatics Association : JAMIA|March 31, 2016
Toward a better understanding of task demands, workload, and performance during physician-computer interactionsLukasz M Mazur, Prithima R Mosaly, Carlton Moore, et al.
Frontiers in Oncology|February 8, 2017
Evaluation of PET/MRI for Tumor Volume Delineation for Head and Neck CancerKyle Wang, Brandon T Mullins, Aaron D Falchook, et al.
Pageof 3